entertainment -WSS

entertainment

author：hotspot 2025-09-04 22:17:25 - browse：27228

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Amylyx ALS drug failure raises questions and concerns

entertainment

WSS

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The battle over the Brookhaven Landfill on Long Island

UnitedHealth quietly bought dozens of outpatient centers

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Novo Nordisk obesity pill bests Wegovy in early trial

Sen. Paul opposes bill to ban Chinese biotechs

knowledge

entertainment

focus

Affirmative action in medical school literally saved lives

In areas with more Black doctors, Black people live longer

Continuity nursing helped my family in our darkest PICU moments

3 hurdles to bringing medical devices to the U.S. market

Jerome Adams on the need for new antivirals for Covid

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Dobbs anniversary: the lost opportunity of abortion as health care

CDC marks new Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The Readout: Amylyx, Alumis, and Lundbeck drug updates

leisure time

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

WATCH: Why do fingernails fall off when they're damaged?

IVF, abortion rights issues kick off Biden’s State of the Union

What it’s like to watch children die of measles

New guidelines on severe brain injury complicate already difficult decisions

Death of patient in Alzheimer’s trial raises question of possible risks

focus

hotspot

entertainment

leisure time